100 related articles for article (PubMed ID: 7628088)
1. Immunometric assays of luteinizing hormone (LH): differences in recognition of plasma LH by anti-intact and beta-subunit-specific antibodies in various physiological and pathophysiological situations.
Mitchell R; Hollis S; Crowley V; McLoughlin J; Peers N; Robertson WR
Clin Chem; 1995 Aug; 41(8 Pt 1):1139-45. PubMed ID: 7628088
[TBL] [Abstract][Full Text] [Related]
2. Undetectable luteinizing hormone levels using a monoclonal immunometric assay.
Barbé F; Legagneur H; Watrin V; Klein M; Badonnel Y
J Endocrinol Invest; 1995 Nov; 18(10):806-8. PubMed ID: 8787959
[TBL] [Abstract][Full Text] [Related]
3. European collaborative study on luteinizing hormone assay: 2. Discrepancy among assay kits is related to variation both in standard curve calibration and epitope specificity of kit monoclonal antibodies.
Costagliola S; Niccoli P; Florentino M; Carayon P
J Endocrinol Invest; 1994 Jun; 17(6):407-16. PubMed ID: 7523480
[TBL] [Abstract][Full Text] [Related]
4. A comparison of 13 different immunometric assay kits for gonadotropins: implications for clinical investigation.
Taylor AE; Khoury RH; Crowley WF
J Clin Endocrinol Metab; 1994 Jul; 79(1):240-7. PubMed ID: 8027235
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of invisible or partially visible luteinizing hormone.
Martin-Du-Pan RC; Horak M; Bischof P
Hum Reprod; 1994 Nov; 9(11):1987-90. PubMed ID: 7868661
[TBL] [Abstract][Full Text] [Related]
6. The bio/immuno ratio of plasma luteinizing hormone does not change during the endogenous secretion pulse: reanalysis of the concept using improved immunometric techniques.
Huhtaniemi I; Ding YQ; Tähtelä R; Välimäki M
J Clin Endocrinol Metab; 1992 Dec; 75(6):1442-5. PubMed ID: 1464645
[TBL] [Abstract][Full Text] [Related]
7. European collaborative study of luteinizing hormone assay: 1. Epitope specificity of luteinizing hormone monoclonal antibodies and surface mapping of pituitary and urinary luteinizing hormone.
Costagliola S; Niccoli P; Florentino M; Carayon P
J Endocrinol Invest; 1994 Jun; 17(6):397-406. PubMed ID: 7523479
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody-based discrepancies between two-site immunometric tests for lutropin.
Pettersson K; Ding YQ; Huhtaniemi I
Clin Chem; 1991 Oct; 37(10 Pt 1):1745-8. PubMed ID: 1914178
[TBL] [Abstract][Full Text] [Related]
9. Is an immunoassay available for the measurement of bioactive LH in serum?
Rosenfield RL; Helke J
J Androl; 1992; 13(1):1-10. PubMed ID: 1551801
[TBL] [Abstract][Full Text] [Related]
10. LH levels in women with polycystic ovarian syndrome: have modern assays made them irrelevant?
Milsom SR; Sowter MC; Carter MA; Knox BS; Gunn AJ
BJOG; 2003 Aug; 110(8):760-4. PubMed ID: 12892688
[TBL] [Abstract][Full Text] [Related]
11. Measurement of plasma free luteinizing hormone beta-subunit in women.
Couzinet B; Pantel J; Chanson P; Young J; Brailly S; Huhtaniemi IT; Bidart JM; Schaison G
J Clin Endocrinol Metab; 2000 Jun; 85(6):2293-8. PubMed ID: 10852466
[TBL] [Abstract][Full Text] [Related]
12. Interpretations of five monoclonal immunoassays of lutropin and follitropin: effects of normalization with WHO standard.
Vermes I; Bonte HA; v d Sluijs Veer G; Schoemaker J
Clin Chem; 1991 Mar; 37(3):415-21. PubMed ID: 1900742
[TBL] [Abstract][Full Text] [Related]
13. An immunologically anomalous luteinizing hormone variant in a healthy woman.
Pettersson K; Ding YQ; Huhtaniemi I
J Clin Endocrinol Metab; 1992 Jan; 74(1):164-71. PubMed ID: 1727817
[TBL] [Abstract][Full Text] [Related]
14. Biologically active luteinizing hormone (LH) in plasma: II. Comparison with immunologically active LH levels throughout the human menstrual cycle.
Romańi P; Robertson DM; Diczfalusy ED
Acta Endocrinol (Copenh); 1977 Apr; 84(4):697-712. PubMed ID: 576756
[TBL] [Abstract][Full Text] [Related]
15. Comparison of luteinizing hormone pulsatility in the serum of women suffering from polycystic ovarian disease using a bioassay and five different immunoassays.
Imse V; Holzapfel G; Hinney B; Kuhn W; Wuttke W
J Clin Endocrinol Metab; 1992 May; 74(5):1053-61. PubMed ID: 1569153
[TBL] [Abstract][Full Text] [Related]
16. Differences in serum luteinizing hormone measurements by immunoradiometric assay induced by kinetic manipulation of assay conditions are dependent on the endocrine milieu of serum.
Olukoga AO; Mitchell R; Walton L; Robertson WR; Laing I
Ann Clin Biochem; 1996 Mar; 33 ( Pt 2)():107-11. PubMed ID: 8729717
[TBL] [Abstract][Full Text] [Related]
17. Biologically active luteinizing hormone (LH) in plasma. V. A re-analysis of the differences in the ratio of biological to immunological LH activities during the menstrual cycle.
Robertson DM; Puri V; Lindberg M; Diczfalusy E
Acta Endocrinol (Copenh); 1979 Dec; 92(4):615-26. PubMed ID: 575264
[TBL] [Abstract][Full Text] [Related]
18. Screening of the mutations in luteinizing hormone beta-subunit in patients with menstrual disorders.
Suganuma N; Furui K; Furuhashi M; Asada Y; Kikkawa F; Tomoda Y
Fertil Steril; 1995 May; 63(5):989-95. PubMed ID: 7720944
[TBL] [Abstract][Full Text] [Related]
19. Hereditary abnormality of luteinizing hormone resulting in discrepant serum concentrations determined by different assays.
Okuda K; Takamatsu J; Okazaki T; Yamada T; Saeki M; Sugimoto O
Endocr J; 1994 Dec; 41(6):639-44. PubMed ID: 7704087
[TBL] [Abstract][Full Text] [Related]
20. European collaborative study of LH assay: 3. relationship of immunological reactivity, biological activity and charge of human luteinizing hormone.
Niccoli P; Costagliola S; Patricot MC; Mallet B; Benahmed M; Carayon P
J Endocrinol Invest; 1996 May; 19(5):260-7. PubMed ID: 8796333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
